Trial in progress: A phase Ib/II study to evaluate the safety and efficacy of atezolizumab plus bevacizumab as adjuvant therapy following carbon ion radiotherapy in hepatocellular carcinoma (VANGUARD trial).

Authors: Keisuke Koroki, Hirokazu Makishima, Sadahisa Ogasawara, Masaru Wakatsuki, Asahi Takahashi, Masanori Inoue, Masato Nakamura, Naoya Kanogawa, Yoshihito Ozawa, Yosuke Inaba, Tomoya Kurokawa, Tetsuro Isozaki, Makoto Shinoto, Masayuki Ohtsuka, Tatsuya Ohno, Yoshiyuki Ueno, Junji Furuse, Masatoshi Kudo, Hideki Hanaoka, Hitoshi Ishikawa

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.tps4222

Source: Full article

---

Abstract

TPS4222